Henlius Biopharmaceuticals, Inc. focuses on development and commercilaization of mAb-based therapeutics using state-of-the-art technologies.
Pursuing higher standard of quality is always our first priority in our business strategy. We work relentlessly, at any tie and under any condition, for the Research & Development of products with the highest qualities.
By adopting the most advanced and latest technologies, Henlius achieves higher quality with lower cost in both R&D and manufacturing. Henlius embraces a people-oriented culture.
While we make endeavor to meet the needs and expectations of patients and their families on health and quality of life, we pay emphasis on the nurture of our staff as well. Everyone here is encouraged to live their own value, to pursue true fulfillment and beyond.